4processed
Form 4 — Insider Transaction
Bicara Therapeutics Inc.(BCAX)
Filing Date
May 18, 2026
Accepted
May 18, 2026
Accession No.
0001628280-26-036885
CIK
0002023658
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Mazumdar Claire | Chief Executive Officer | Other | 15.0K | $3.79 | — | 377.2K | Common Stock | May 18, 2026 |
| Mazumdar Claire | Chief Executive Officer | Other | 12.0K | $19.962 | — | 365.1K | Common Stock | May 18, 2026 |
| Mazumdar Claire | Chief Executive Officer | Other | 3.0K | $20.348 | — | 362.2K | Common Stock | May 18, 2026 |
| Mazumdar Claire | Chief Executive Officer | Other | 15.0K | $0 | — | 146.1K | Stock Option (Right to Buy) | May 18, 2026 |